The new California sites will join participating sites in Florida and Ontario who access clinicalRSVP.com to check subject eligibility requirements before dosing commences. The addition of the two West Coast sites expands the reach of the clinicalRSVP site network, as well as strengthens the relevance of the network for participating sites. The goal of clinicalRSVP.com is to provide a single continental registry for all Phase 1 investigators to check and report subject eligibility criteria, thereby improving data integrity for sponsors and trial safety for participants.
ClinicalRSVP.com began operating in 2009 with five sites located in South Florida, and has since grown the network to eighteen (18) Phase 1 units across the US and Canada. ClinicalRSVP.com recently exhibited at the American College of Clinical Pharmacology (ACCP) Annual Meeting in Chicago, from September 11-13 and anticipates rapid future growth for the network.
The President of clinicalRSVP.com, Darran Boyer, commented “The addition of two outstanding sites in California represents a terrific advancement for clinicalRSVP and for those who sponsor and conduct Phase 1 clinical trials across North America. We are pleased that the network now spans from coast to coast and into Canada, and we see the continued growth of this Phase 1 network as a positive sign of things to come. We will continue to promote the advancements achieved through clinicalRSVP as we look to join Phase 1 Units across the US and Canada.”
About ClinicalRSVP.com
ClinicalRSVP is the nationwide network that prevents research volunteers from enrolling in multiple concurrent research studies. This blinded cooperative registry allows investigators to confidentially and securely verify subject eligibility requirements prior to subject enrollment in clinical trials, resulting in advances to clinical research data integrity and participant safety.
For more information about clinicalRSVP, visit www.clinicalrsvp.com